Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms, Nerve Tissue 1Neoplasms 1Glioma 1Glioblastoma 1Brain Neoplasms 1

Interventions

pembrolizumab 282Carboplatin 217Cisplatin 147Gemcitabine 146Paclitaxel 142Bevacizumab 116Pemetrexed 114Docetaxel 101Oxaliplatin 79durvalumab 78Dexamethasone 77Fluorouracil 76atezolizumab 75Nivolumab 75Cyclophosphamide 74130-nm albumin-bound paclitaxel 71Fulvestrant 70Capecitabine 64Cetuximab 63Injections 62Leucovorin 60Rituximab 55fludarabine 50Lenalidomide 50venetoclax 44Prednisone 43Irinotecan 42Letrozole 40enzalutamide 39tislelizumab 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Microbubbles × 90 days × Clear all
NCT06496971 2026-04-09

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

NaviFUS Corporation

Phase 3 Recruiting
32 enrolled
CNS

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡